Page 8 - இரண்டாவது பார்வை மருத்துவ ப்ராடக்ட்ஸ் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Continuation of the business combination project between Pixium Vision et Second Sight Medical Products Second Sight ») (Nasdaq: EYES) continues under the terms announced to the market on January 6, 2021. The company is working with Second Sight to satisfy the closing conditions to the combination, which is currently anticipated to be completed during the second quarter of 2021. In addition, the President of the Paris Commercial Court has appointed, by order dated January 18, 2021, Mr. Olivier Péronnet and Mr. Gilles de Courcel as contribution appraiser, whose conclusions will be made available to the Pixium Vision s shareholders. As a reminder, the completion of the transaction is notably subject to the following conditions precedent:

France generalStanford universityUnited statesUnited kingdomNordrhein westfalenCity ofComunidad autonoma de catalunaGuillaume renondinEntreprise innovanteGuillaume van renterghemSophie baumontRisk factors of the companyEuropean select growth opportunities fundSecond sight medical products incInstitute of ocular microsurgeryParis commercial court